Galapagos NV

Galapagos NV

Sector: Pharmaceutical Preparations Region: Belgium

: | OTC Markets: GLPYY | London Stock Exchange: 0JXZ | Euronext Amsterdam: GLPG

Similar to: Guerbet SA, Pernix Therapeutics Holdings, Inc., AstraZeneca Plc

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. The company operates through two operating divisions: Research and Development and Services. The Research and Development division develops medicines based on novel mode-of-action. The Service division offers target-to-drug discovery products and services to pharmaceutical and biotech companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates. The company was founded by Onno van de Stolpe and Rudi Pauwels in 1999 and is headquartered in Mechelen, Belgium.

News & Analysis

You may also be interested in: